Form 4 Filing for FibroBiologics, Inc. - Stock Option Grant to Director

Matthew Link, a director at FibroBiologics, Inc. (FBLG), was granted 30,803 stock options on June 23, 2026. These options, with an exercise price of $0.7503, are for the company's Common Stock and will vest in full on the earlier of the first anniversary of the grant date or the next annual meeting. The options expire on June 22, 2036. This transaction is reported on Form 4.